The May 2024 action was a proposed rule, not an immediate reclassification, so marijuana generally remained in Schedule I pending formal rulemaking. By 2026, however, the record included a separate Schedule III action for state medical marijuana, making the statement too broad without that qualification.
Mostly True
The DEA announced a proposed Schedule III classification for marijuana in May 2024, but the drug remained in Schedule I unless and until a final rule took effect.
Federal Marijuana Rescheduling: Process and Impact | Moritz College of Law
Source: moritzlaw.osu.edu
At a glance
Verified August 31, 2026Key Evidence
The May 2024 measure was a proposed rule to move marijuana from Schedule I to Schedule III, not a final rescheduling decision.
A proposed rule does not itself complete the change, and later summaries continued to describe the broader rescheduling as dependent on final agency action.
The statement omits a later development: by April 2026, the DEA had reportedly placed state medical marijuana in Schedule III while setting an expedited hearing on whether broader rescheduling should occur.
The reporting
What the Evidence Shows
In May 2024, the federal government proposed moving marijuana from Schedule I to Schedule III under the Controlled Substances Act. The proposal was published as a notice of proposed rulemaking, meaning it began a formal process rather than immediately changing marijuana’s legal classification. The proposal was issued on May 16 and published in the Federal Register on May 21, according to legal analyses from Holland & Knight and Morgan Lewis.hklaw.comhklaw.comU.S. Drug Enforcement Administration Proposes Reclassification of Marijuana |...
morganlewis.commorganlewis.comFrom Prohibition to Prescription: DEA Issues Proposed Rule to Reschedule...
Primary trail
Verified Sources10
Open source